Trial Profile
Multicenter Phase I/II Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 28 Apr 2021 Status changed from active, no longer recruiting to completed.
- 05 Mar 2019 Planned End Date changed from 1 Oct 2019 to 1 Mar 2020.
- 05 Mar 2019 Status changed from recruiting to active, no longer recruiting.